FDA Greenlights Nevro Leads

April 18, 2016

The FDA has approved Nevro’s new surgical leads, which are intended for use with Senza Spinal Cord Stimulation, a neuromodulation platform delivering HF10 therapy.

The SCS therapy system delivers electrical pulses via a compact battery-powered generator implanted under the skin located near the spinal cord to treat chronic leg and back pain. — Joya Patel